Buy 2 MILLIPLEX Kits and Get the 3rd FREE
For the month of February only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
13Feb
News
06Nov
New Product – MILLIPLEX Bovine Cytokine/Chemokine Panel 1
Inflammation plays a central role in the aetiology of many immunologically related diseases, such as infectious disease, osteoarthritis and respiratory disease, as well as neurologic, metabolic and cardiovascular disease and cancer.
10Jul
Bring Your Biomarkers to Life
As your research uncovers the significant role of biomarkers in normal and disease states, you need a reliable partner for quality assays and consistent performance.
05Mar
Latest Merck Analyte Update Now Available!
Your latest comprehensive guide to multiplex and Single Protein Detection assays is now available!
06Nov
Buy 2 MILLIPLEX Kits and Get the 3rd FREE
NEW ZEALAND OFFER – For the month of November only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
02Oct
NEW Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel
New Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel, a 15-plex customisable panel.
30Sep
Buy 2 MILLIPLEX Kits and Get the 3rd FREE
For the month of October only, buy 2 MILLIPLEX Kits and receive the 3rd FREE.
18Sep
Launch of the Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only)
Being the third¹ liquid biopsy test for Biocartis, the newly launched assay, Idylla™ ctNRAS-BRAF-EGFR S492R Mutation Assay (Research Use Only), also marks an important milestone in the partnership with the leading science and technology company Merck².
18Sep
Biocartis launches second liquid biopsy assay
Biocartis, an innovative molecular diagnostics company, today announces the launch of its second liquid biopsy assay, the Idylla™ ctKRAS Mutation Assay (Research Use Only, RUO), which was developed in partnership with the leading science and technology company Merck1 on Biocartis’ molecular diagnostics platform Idylla™.